 |
|
Evidence-based Guidelines for the Treatment of Helicobacter pylori Infection in Korea: 2020 Revised Edition
Hye-Kyung Jung, Seung Joo Kang, Yong Chan Lee, Hyo-Joon Yang, Seon-Young Park, Cheol Min Shin, Sung Eun Kim, Hyun Chul Lim, Jie-Hyun Kim, Su Youn Nam, Woon Geon Shin, Jae Myung Park, Il Ju Choi, Jae Gyu Kim, Miyoung Choi,
Korean J Helicobacter Up Gastrointest Res. 2020;20(4):261-287. Published online 2020 Nov 16 DOI: https://doi.org/10.7704/kjhugr.2020.0045
|
|
Citations to this article as recorded by
 Various Diagnostic Methods for Helicobacter pylori Infection
Han Jo Jeon, Hyuk Soon Choi
The Korean Journal of Medicine.2024; 99(2): 104. CrossRef Approach to Patients with Consecutive Helicobacter pylori Eradication Failure
Sung Eun Kim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(1): 15. CrossRef Is Probiotic Supplementation Useful for Helicobacter pylori Eradication?
Ki-Nam Shim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(1): 1. CrossRef Tailored Therapy Using Bismuth Add-on Standard Triple Therapy vs. Concomitant Therapy: A First-line Regimen for Helicobacter pylori Infection
Soo Yeon Choi, Na Rae Lim, Woo Chul Chung
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(2): 118. CrossRef Eradication of Helicobacter pylori Infection Using 7-day PCR-based Tailored Therapy
Youngwoo Kim, Heejun Kang, Sang-Gon Moon, Bohyoung Kim, Hyeyeon Lee, Chul-Hyun Lim, Jung-Hwan Oh
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(2): 125. CrossRef Bismuth, An Indispensable Component of Helicobacter pylori Eradication Therapy
Kyung Ho Song
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(2): 79. CrossRef Optimal treatment duration of bismuth-containing quadruple therapy in Helicobacter pylori infection: A retrospective study
Ji Yoon Kim, Sang Gyun Kim, Soo-Jeong Cho
Medicine.2023; 102(48): e36310. CrossRef Does Types of 23S-Ribosomal RNA Point Mutations Affect Helicobacter pylori Eradication Rate in Clarithromycin-Based Triple Therapy?
Da Hyun Jung
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2023; 23(4): 237. CrossRef The Influence of Past Metronidazole Exposure on the Outcome of Helicobacter pylori Eradication
Younghee Choe, Joon Sung Kim, Hyun Ho Choi, Dae Bum Kim, Jae Myung Park, Jung Hwan Oh, Tae Ho Kim, Dae Young Cheung, Woo Chul Chung, Byung-Wook Kim, Sung Soo Kim
Frontiers in Microbiology.2022;[Epub] CrossRef Eradication Rate Using a First-line Triple Therapy for Helicobacter pylori Infection in Yeongdong, Gangwon Province, Korea
Eun Jeong Gong, Chang Seok Bang, Myeongsook Seo, Hyun Il Seo, Jong Kyu Park, Sang Jin Lee, Koon Hee Han, Woo Jin Jeong, Young Don Kim, Gab Jin Cheon
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(2): 139. CrossRef Why Is Regional Helicobacter pylori Eradication Treatment Report Important?
Ju Yup Lee
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(2): 83. CrossRef Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial
Seung In Seo, Hyun Lim, Chang Seok Bang, Young Joo Yang, Gwang Ho Baik, Sang Pyo Lee, Hyun Joo Jang, Sea Hyub Kae, Jinseob Kim, Hak Yang Kim, Woon Geon Shin
Gut and Liver.2022; 16(5): 697. CrossRef Clinical Characteristics and Treatment Pathway of Patients Treated with Helicobacter pylori Infection-A Single Center Cohort Study Using Common Data Model
Seung In Seo, Tae Jun Kim, Yoon Jin Choi, Chang Seok Bang, Yong Kang Lee, Moon Won Lee, Su Youn Nam, Woon Geon Shin
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(3): 214. CrossRef Criteria for the National Health Insurance Service Medical Care Benefit of Helicobacter pylori Treatment
Young-Il Kim, Il Ju Choi
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2022; 22(3): 235. CrossRef The Current Strategy of Helicobacter pylori Eradication
Yong Hwan Kwon
The Korean Journal of Medicine.2021; 96(1): 13. CrossRef Screening and Eradication of Helicobacter pylori for Gastric Cancer Prevention
Hyunchul Lim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(2): 168. CrossRef Cost-Effectiveness, Efficacy, and Safety Analysis of Tailored Therapy in Patients with Helicobacter pylori Infection
A Reum Choe, Ki-Nam Shim, Yehyun Park, Eun-Mi Song, Chung Hyun Tae, Sung-Ae Jung
Journal of Clinical Medicine.2021; 10(12): 2619. CrossRef Recent Changes in the Treatment of Helicobacter pylori Infection in Children and Adolescents
Ji-Hyun Seo, Ji Sook Park, Hee-Shang Youn
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(3): 188. CrossRef Helicobacter pylori Eradication Therapy-associated Diarrhea
Hoon Gil Jo, Yong Sung Kim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(3): 203. CrossRef Bismuth-containing Standard Triple Therapy the First-line Eradication Therapy for Helicobacter pylori
Yeon-Ji Kim, Woo Chul Chung
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2021; 21(4): 354. CrossRef ROLE OF INTERLEUKIN-2, INTERLEUKIN-4 AND CLUSTER OF DIFFERENTIATION-22 AS AN IMMUNE MARKERS IN INDIVIDUALS INFECTED WITH Helicobacter pylori
Jaffar Muhammad Baqir Muhammad Rashad, Ahmed Abdul jabbar Jaloob Aljanaby
Journal of Experimental Biology and Agricultural Sciences.2021; 9(3): 388. CrossRef
|